Stocks · News reference
Heart Test Laboratories Q1 EPS $(0.86) Up From $(1.58) YoY, Sales $2.100K Up From $1.900K YoY
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.86) per share. This is a 45.57 percent increase over losses of $(1.58) per share from the same period last year. The company reported $2.100
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
FDA Grants 510(k) Clearance For HeartSciences’ MyoVista wavECGTM Device As 12-Lead Resting Electrocardiograph
HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or
Why Option Care Health Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Option Care Health jumped 23.8% on reports McKesson and CD&R may acquire it; Freight Technologies led gainers, while NFT Ltd. led decliners.
Reported Earlier, Fortitude, Expected To Become Public Via Proposed HeartSciences Combination, Secures Priority BITMAIN Zcash Equipment Allocation With Up To $100M Non-Binding Commitment